FeesSafety
Pluang+

Aptos launches three privacy layers on mainnet, enhancing user confidentiality for identity, amounts, and transaction intent.

Protocol Fundamentals
23 Oct 2026
Crypto Briefing
View Source
Bullish
Aptos launches three privacy layers on mainnet, enhancing user confidentiality for identity, amounts, and transaction intent.

Aptos has introduced three opt-in privacy features on its mainnet: Keyless Accounts, Confidential APT, and an Encrypted Mempool. These layers protect user identity, transaction amounts, and transaction intent respectively, while keeping addresses visible for compliance. The features are accessible mainly through the Petra Wallet and come with a higher gas fee for encrypted transactions. This update aims to balance privacy with transparency, targeting private payments and treasury operations while maintaining audit trails for compliance.

Aptos' new privacy features on mainnet provide context for readers following cryptocurrency markets. As of Oct 23, 2026 20:03 WIB, 29 of 50 major cryptocurrencies on Pluang rose while 20 fell. Notable movers include COMP at Rp438.382 with a 1-day change of -2.81%, CRV at Rp6.541 down 2.65%, and GRT at Rp434 up 2.60%.

More News

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Global zinc supply is expected to fall short by 88,000 tonnes in 2026 amid declining mine production, while tin demand is projected to outpace supply growth through 2035. This has renewed exploration in historic polymetallic mining districts in the U...

Market News
Bullish
43 minutes ago
Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...

Market News
Bullish
1 hour ago
Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...

Company Fundamentals
Bullish
1 hour ago
Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...

Company Fundamentals
Bullish
1 hour ago
eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...

Others
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App